カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の遺伝子合成（研究用）市場2023-2030：方法別（固相、チップベース）、研究フェーズ別（前臨床、臨床）、用途別、サービス別、エンドユーザー別

【英語タイトル】Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV123）・商品コード：GRV23NOV123
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

遺伝子合成（研究用）"市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の遺伝子合成（研究用）市場規模は2030年までに51.4億米ドルに達すると予測され、2023年から2030年までのCAGRは16.1%で成長する見込みです。市場成長の主な要因は、研究開発活動の増加、市場競争の激化、合成生物学分野の開発の高まりです。遺伝子合成に関連する幅広い用途も市場成長の原動力になると予測されています。遺伝子合成に関わる方法には独自の利点があり、広く使用することが可能です。例えば、遺伝子合成に関わる固相合成技術では、溶液相の試薬を過剰に使用することで合成反応を加速することができます。

また、各ステップ後の精製工程を必要とせずに実施することができます。さらに、この方法は合成プロセスの効率化にも役立ちます。このため、Agilent TechnologyやBlue Heron Biotechなど、複数の企業が遺伝子合成に固相合成法を使用しています。市場の成長は、合成生物学や遺伝子合成の研究開発活動への関心の高まりにより、ここ数年で大きく促進されました。また、合成生物学や遺伝子合成に関する研究活動を行う研究機関や大学が設立されていることも、市場の成長を支えるものと期待されています。例えば、コペンハーゲン大学の合成生物学センターは、デンマークで合成生物学の研究を行っている主要な学科の1つです。

また、遺伝子合成市場の大手企業であるIntegrated DNA Technologies（IDT）は、2023年2月に、インパクトのある研究と技術開発のために業界パートナーと研究者を結びつけるCollab Networkを導入しました。これらの要因は、今後数年間における遺伝子合成の成長を増強すると予想されます。さらに、業界競争の激化は遺伝子合成サービスを強化します。主要企業は、費用対効果の高いサービスを提供し、業界での地位を強化するために様々なアプローチを実施しています。これらの市場プレーヤーは、市場の今後の機会に焦点を当てています。例えば、遺伝子合成企業であるEvonetix社のチームは、ロサンゼルスで開催されたSynthetic Biology: Engineering, Evolution & Design (SEED) 2023カンファレンスに参加し、合成生物学の進歩を理解しました。

遺伝子合成（研究用）市場レポートハイライト

- 固相合成セグメントは、この方法が提供する様々な利点と利点、および多くのプレーヤーによる高い採用により、2022年に最も高い収益シェアを目撃しました。

- 抗体DNA合成サービス分野は、遺伝子合成の高い採用率と抗体開発におけるその有効性により、2022年に最大の収益シェアを獲得しました。

- 遺伝子・細胞治療開発アプリケーション分野は2022年に最大の収益シェアを占め、予測期間中に最も速いCAGRを記録する見込みです。遺伝子・細胞治療開発活動の増加がセグメント成長を促進しています。

- 臨床研究段階セグメントは2022年に最大の収益シェアを占め、予測期間中に最も速いCAGRを記録する見込みです。政府の支援政策と遺伝子治療開発における遺伝子合成の重要な役割がセグメント成長を促進すると予測されています。

- 学術・政府研究機関のエンドユースセグメントが2022年に最大のシェアを占めました。合成生物学研究への関心の高まりと重点化が同分野の成長を促進すると予測されています。

- 北米は、同地域に様々な有力企業が存在することから、2022年に最大の市場シェアを獲得しました。アジア太平洋地域は、治療薬開発のための研究活動の増加により、予測期間中に最も速いCAGRを記録すると予測されています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 市場変数・傾向・範囲
第4章 世界の遺伝子合成（研究用）市場：方法別予測・傾向分析
第5章 世界の遺伝子合成（研究用）市場：サービス別予測・傾向分析
第6章 世界の遺伝子合成（研究用）市場：用途別予測・傾向分析
第7章 世界の遺伝子合成（研究用）市場：研究フェーズ別予測・傾向分析
第8章 世界の遺伝子合成（研究用）市場：エンドユーザー別予測・傾向分析
第9章 世界の遺伝子合成（研究用）市場：地域別予測・傾向分析
第10章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Market definitions
1.2. Information Procurement
1.2.1. Market formulation & data visualization
1.2.2. Data validation & publishing
1.3. Research Assumptions
1.4. Research Methodology
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.1.1. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. Global Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Obective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising investment in synthetic biology market
3.3.1.2. Advent of enzymatic DNA synthesis process
3.3.1.3. Technological advancements in the DNA synthesis platforms
3.3.1.4. Declining price of DNA synthesis & sequencing
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of skilled professionals
3.3.2.2. Misuse of gene synthesis
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.3. COVID-19 Impact Analysis
Chapter 4. Gene Synthesis (Research Use) Market: Method Estimates & Trend Analysis
4.1. Global Gene Synthesis (Research Use) Market: Method Movement Analysis
4.2. Solid-phase Synthesis
4.2.1. Solid Phase Synthesis Market, 2018 – 2030 (USD Million)
4.3. Chip-based Synthesis
4.3.1. Chip Based Synthesis Market, 2018 – 2030 (USD Million)
4.4. PCR-based Enzyme Synthesis
4.4.1. PCR based Enzyme Synthesis Market, 2018 – 2030 (USD Million)
Chapter 5. Gene Synthesis (Research Use) Market: Service Estimates & Trend Analysis
5.1. Global Gene Synthesis (Research Use) Market: Services Movement Analysis
5.2. Antibody DNA Synthesis
5.2.1. Antibody DNA Synthesis Market, 2018 – 2030 (USD Million)
5.3. Viral DNA Synthesis
5.3.1. Viral DNA Synthesis Market, 2018 – 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. Gene Synthesis (Research Use) Market: Application Estimates & Trend Analysis
6.1. Global Gene Synthesis (Research Use) Market: Application Movement Analysis
6.2. Gene & Cell Therapy Development
6.2.1. Gene & Cell Therapy Development Market, 2018 – 2030 (USD Million)
6.3. Vaccine Development
6.3.1. Vaccine Development Market, 2018 – 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Gene Synthesis (Research Use) Market: Research Phase Estimates & Trend Analysis
7.1. Global Gene Synthesis (Research Use) Market: Research Phase Movement Analysis
7.2. Preclinical
7.2.1. Preclinical Market, 2018 – 2030 (USD Million)
7.3. Clinical
7.3.1. Clinical Market, 2018 – 2030 (USD Million)
Chapter 8. Gene Synthesis (Research Use) Market: End-use Estimates & Trend Analysis
8.1. Global Gene Synthesis (Research Use) Market: End-use Movement Analysis
8.2. Biopharmaceutical & Pharmaceutical Companies
8.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 – 2030 (USD Million)
8.3. Academic & Government Research Institutes
8.3.1. Academic & Government Research Institutes Market, 2018 – 2030 (USD Million)
8.4. Contract Research Organizations
8.4.1. Contract Research Organizations Market, 2018 – 2030 (USD Million)
Chapter 9. Gene Synthesis (Research Use) Market: Region Estimates & Trend Analysis
9.1. Gene Synthesis (Research Use) Market: Region Outlook
9.2. North America
9.2.1. North America gene synthesis (research use) market estimates and forecast, 2018 – 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Regulatory Framework
9.2.2.5. U.S. gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Canada gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3. Europe
9.3.1. Europe gene synthesis (research use) market estimates and forecast, 2018 – 2030 (USD Million)
9.3.2. Germany
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. Germany gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.3. France
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. France gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. UK gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Italy gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Spain gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Denmark gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Sweden gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Norway gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.10. The Netherlands
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. The Netherlands gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.11. Switzerland
9.3.11.1. Key Country Dynamics
9.3.11.2. Target Disease Prevalence
9.3.11.3. Competitive Scenario
9.3.11.4. Regulatory Framework
9.3.11.5. Switzerland gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific gene synthesis (research use) market estimates and forecast, 2018 – 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. Japan gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. China gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. India gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Australia gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. South Korea gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Thailand gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America gene synthesis (research use) market Estimates And Forecast, 2018 – 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Brazil gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Mexico gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Argentina gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6. Middle East & Africa
9.6.1. Middle East & Africa gene synthesis (research use) market Estimates And Forecast, 2018 – 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Saudi Arabia gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. South Africa gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. UAE gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Kuwait gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Share Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. GenScript
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Method Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Azenta, Inc. (GENEWIZ)
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Method Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Boster Biological Technology
10.4.3.1. Overview
10.4.3.2. Method Benchmarking
10.4.3.3. Strategic Initiatives
10.4.4. Twist Bioscience
10.4.4.1. Overview
10.4.4.2. Method Benchmarking
10.4.4.3. Strategic Initiatives
10.4.5. ProteoGenix, Inc
10.4.5.1. Overview
10.4.5.2. Method Benchmarking
10.4.5.3. Strategic Initiatives
10.4.6. Biomatik.
10.4.6.1. Overview
10.4.6.2. Method Benchmarking
10.4.6.3. Strategic Initiatives
10.4.7. ProMab Biotechnologies, Inc.
10.4.7.1. Overview
10.4.7.2. Method Benchmarking
10.4.7.3. Strategic Initiatives
10.4.8. Thermo Fisher Scientific, Inc
10.4.8.1. Overview
10.4.8.2. Method Benchmarking
10.4.8.3. Strategic Initiatives
10.4.9. Integrated DNA Technologies, Inc. (Danaher)
10.4.9.1. Overview
10.4.9.2. Method Benchmarking
10.4.9.3. Strategic Initiatives
10.4.10. OriGene Technologies, Inc.
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Method Benchmarking
10.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 4 Global gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 5 Global gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 6 Global gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 7 Global gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 8 North America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 9 North America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 10 North America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 11 North America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 12 North America synthesis market by Application, 2018 - 2030 (USD Million)
Table 13 U.S. gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 14 U.S. gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 15 U.S. gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 16 U.S. gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 17 U.S. gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 18 Canada gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 19 Canada gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 20 Canada gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 21 Canada gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 22 Canada gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 23 Europe gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 24 Europe gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 25 Europe gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 26 Europe gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 27 Europe gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 28 UK gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 29 UK gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 30 UK gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 31 UK gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 32 UK gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 33 Germany gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 34 Germany gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 35 Germany gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 36 Germany gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 37 Germany gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 38 France gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 39 France gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 40 France gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 41 France gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 42 France gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 43 Italy gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 44 Italy gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 45 Italy gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 46 Italy gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 47 Italy gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 48 Spain gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 49 Spain gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 50 Spain gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 51 Spain gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 52 Spain gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 53 Denmark gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 54 Denmark gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 55 Denmark gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 56 Denmark gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 57 Denmark gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 58 Sweden gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 59 Sweden gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 60 Sweden gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 61 Sweden gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 62 Sweden gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 63 Norway gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 64 Norway gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 65 Norway gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 66 Norway gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 67 Norway gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 68 The Netherlands gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 69 The Netherlands gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 70 The Netherlands gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 71 The Netherlands gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 72 The Netherlands gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 73 Switzerland gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 74 Switzerland gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 75 Switzerland gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 76 Switzerland gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 77 Switzerland gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 78 Asia Pacific gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 79 Asia Pacific gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 80 Asia Pacific gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 81 Asia Pacific gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 82 Asia Pacific gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 83 Japan gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 84 Japan gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 85 Japan gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 86 Japan gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 87 Japan gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 88 China gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 89 China gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 90 China gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 91 China gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 92 China gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 93 India gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 94 India gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 95 India gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 96 India gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 97 India gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 98 Australia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 99 Australia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 100 Australia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 101 Australia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 102 Australia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 103 Thailand gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 104 Thailand gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 105 Thailand gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 106 Thailand gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 107 Thailand gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 108 South Korea gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 109 South Korea gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 110 South Korea gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 111 South Korea gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 112 South Korea synthesis market by Research Phase, 2018 - 2030 (USD Million)
Table 113 Latin America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 114 Latin America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 115 Latin America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 116 Latin America gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 117 Latin America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 118 Brazil gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 119 Brazil gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 120 Brazil gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 121 Brazil gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 122 Brazil gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 123 Mexico gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 124 Mexico gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 125 Mexico gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 126 Mexico gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 127 Mexico gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 128 Argentina gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 129 Argentina gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 130 Argentina gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 131 Argentina gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 132 Argentina gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 133 Middle East & Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 134 Middle East & Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 135 Middle East & Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 136 Middle East & Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 137 Middle East & Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 143 South Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 144 South Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 145 South Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 146 South Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 147 South Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 148 UAE gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 149 UAE gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 150 UAE gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 151 UAE gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 152 UAE gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 153 Kuwait gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 154 Kuwait gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 155 Kuwait gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 156 Kuwait gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 157 Kuwait gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 158 Participant’s overview
Table 159 Financial performance
Table 160 Key companies undergoing expansions
Table 161 Key companies undergoing acquisitions
Table 162 Key companies undergoing collaborations
Table 163 Key companies launching new products/services
Table 164 Key companies undergoing partnerships
Table 165 Key companies undertaking other strategies

List of Figures

Fig. 1 Global gene synthesis (research use) market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Market trends & outlook
Fig. 18 Porter’s five force analysis
Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
Fig. 20 Global gene synthesis (research use) market: method outlook key takeaways
Fig. 21 Global gene synthesis (research use) market: method movement analysis
Fig. 22 Solid-phase synthesis market, 2018 - 2030 (USD Million)
Fig. 23 Chip-based synthesis market, 2018 - 2030 (USD Million)
Fig. 24 PCR-based enzyme synthesis market, 2018 - 2030 (USD Million)
Fig. 25 Global gene synthesis (research use) market: services outlook and key takeaways
Fig. 26 Global gene synthesis (research use) market: services movement analysis
Fig. 27 Antibody DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 28 Viral DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Global gene synthesis (research use) market: application outlook and key takeaways
Fig. 31 Global gene synthesis (research use) market: application movement analysis
Fig. 32 Gene & cell therapy development market, 2018 - 2030 (USD Million)
Fig. 33 Vaccine development market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Global gene synthesis (research use) market: End-use outlook key takeaways
Fig. 36 Global gene synthesis (research use) market: end-use movement analysis
Fig. 37 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 38 Academic and government research institutes market, 2018 - 2030 (USD Million)
Fig. 39 Contract research organizations market, 2018 - 2030 (USD Million)
Fig. 40 Global gene synthesis (research use) market: research phase outlook and key takeaways
Fig. 41 Global gene synthesis (research use) market: research phase movement analysis
Fig. 42 Preclinical market, 2018 - 2030 (USD Million)
Fig. 43 Clinical market, 2018 - 2030 (USD Million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 North America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 US gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Target disease prevalence, 2022
Fig. 49 Key country dynamics
Fig. 50 Canada gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Target disease prevalence, 2022
Fig. 52 Key country dynamics
Fig. 53 Europe gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UK gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Target disease prevalence, 2022
Fig. 56 Key country dynamics
Fig. 57 Germany gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Target disease prevalence, 2018-2030
Fig. 59 Key country dynamics
Fig. 60 France gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Target disease prevalence 2018-2030
Fig. 62 Key country dynamics
Fig. 63 Spain gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Target disease prevalence 2022
Fig. 65 Key country dynamics
Fig. 66 Italy gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Target disease prevalence 2022
Fig. 68 Key country dynamics
Fig. 69 Denmark gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Target disease prevalence
Fig. 71 Key country dynamics
Fig. 72 Sweden gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Target disease prevalence in Sweden
Fig. 74 Key country dynamics
Fig. 75 Norway gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Target disease prevalence in Norway 2022
Fig. 77 Key country dynamics
Fig. 78 Switzerland gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Target disease prevalence in Switzerland 2022
Fig. 80 Key country dynamics
Fig. 81 The Netherlands gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Target disease prevalence in The Netherlands 2022
Fig. 83 Key country dynamics
Fig. 84 Asia pacific gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Japan gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Target disease prevalence, 2022
Fig. 87 Key country dynamics
Fig. 88 China gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Target disease prevalence, 2018-2030
Fig. 90 Key country dynamics
Fig. 91 India gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Target disease prevalence 2018-2030
Fig. 93 Key country dynamics
Fig. 94 Australia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Target disease prevalence 2022
Fig. 96 Key country dynamics
Fig. 97 Thailand gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Target disease prevalence 2022
Fig. 99 Key country dynamics
Fig. 100 South Korea gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Target disease prevalence
Fig. 102 Key country dynamics
Fig. 103 Latin America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Brazil gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Target disease prevalence in Norway 2022
Fig. 106 Key country dynamics
Fig. 107 Mexico gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Target disease prevalence in Norway 2022
Fig. 109 Key country dynamics
Fig. 110 Argentina gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Target disease prevalence in Norway 2022
Fig. 112 Key country dynamics
Fig. 113 Middle East & Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 Target disease prevalence in Norway 2022
Fig. 115 Key country dynamics
Fig. 116 South Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Target disease prevalence in Norway 2022
Fig. 118 Key country dynamics
Fig. 119 Saudi Arabia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Target disease prevalence in Norway 2022
Fig. 121 Key country dynamics
Fig. 122 UAE gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 123 Target disease prevalence in Norway 2022
Fig. 124 Key country dynamics
Fig. 125 Kuwait gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Target disease prevalence in Norway 2022
Fig. 127 Key country dynamics
Fig. 128 Market participant categorization
Fig. 129 Company market share analysis, 2022
Fig. 130 Strategic framework

★調査レポート[世界の遺伝子合成（研究用）市場2023-2030：方法別（固相、チップベース）、研究フェーズ別（前臨床、臨床）、用途別、サービス別、エンドユーザー別] (コード：GRV23NOV123)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の遺伝子合成（研究用）市場2023-2030：方法別（固相、チップベース）、研究フェーズ別（前臨床、臨床）、用途別、サービス別、エンドユーザー別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の遺伝子合成市場2023-2030：合成法別（固相合成法、チップ合成法、PCR法酵素合成法）、サービス別、用途別、エンドユーザー別、地域別
  • 世界の全ゲノムシーケンス（WGS）市場2023-2030：製品別（器具、消耗品、サービス）、種類別、ワークフロー別、用途別、エンドユーザー別、地域別
  • 世界のin situハイブリダイゼーション（ISH）市場2023-2030：技術別、プローブ別、製品別、用途別、エンドユーザー別、地域別
  • 世界の乳がん針生検（コアニードルバイオプシー/CNB）市場2023-2030：技術別、エンドユーザー別（病院・診断研究所、学術・研究機関）、地域別
  • 世界のカスタム抗体市場2023-2030：種類別（モノクローナル）、サービス別（抗体開発）、ソース別（ネズミ）、用途別、エンドユーザー別、地域別
  • 世界のマイクロRNA市場2024-2030：製品・サービス別（装置、消耗品）、用途別（癌、感染症）、エンドユーザー別、地域別
  • 世界のCRISPR・CAS遺伝子市場2023-2030：製品・サービス別、用途別（バイオメディカル、農業）、エンドユーザー別（バイオテクノロジー、製薬企業）、地域別
  • 世界の中央研究所市場2024-2030：サービス別（遺伝子サービス、バイオマーカーサービス）、エンドユーザー別（製薬企業、バイオテクノロジー企業）、地域別
  • 世界の多血小板血漿（PRP）市場2023-2030：種類別（Pure PRP、LR-PRP）、用途別（整形外科、スポーツ医学、美容外科）、エンドユーザー別、地域別
  • 世界の通信におけるEMS（電子機器製造受託サービス）市場2023-2030：サービス別（電子製造、電子エンジニアリング、電子アセンブリ、サプライチェーンマネジメント）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆